Saturday, February 7, 2026
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Fiinews
No Result
View All Result
Home Manufacturing

India urged to be a world leader in pharma supplies

Fiinews by Fiinews
March 25, 2020
in Manufacturing
Reading Time: 2 mins read
A A
0
Pfizer
0
SHARES
10
VIEWS
LinkedinShare on Twitter

Threat of over dependence on China, warns Sridhar

India needs to be a World leader for not just Generic formulations but APIs (active pharmaceutical ingredients) too, according to S Sridhar, Chair, FICCI Pharmaceuticals Committee and MD, Pfizer.

India’s pharmaceutical import dependence on China, nearly 70% by value, has become a significant threat to the local healthcare manufacturing and global supply chain, Sridhar warned in a message welcoming the Government’s decision on Bulk Drug Parks.

While Indian pharma companies over years have climbed up the value chain to focus on value-added formulations, but this over dependence on China has increased the threat to the nation’s health security as some of these critical and complex APIs are crucial to address India’s growing disease burden.

India should not look at these Bulk Drug Parks only for Domestic requirement. China became big supplier because of scale which looked into both domestic and export requirement, he pointed out.

“Domestic (market) will not give scale and is always exposed to cost and pricing pressures. With this new policy initiative, the Government must look at incentivising the manufacturing of the critical 54 APIs which were recently restricted for exports,” he said on 22 Mar 2020.

He called on the Government and the Industry to work together for not just domestic capacities but fulfilling global export demands too.

The Indian pharma industry has been a world leader in generics markets contributing significantly to the global demand for generics in terms of volume.

‘Made in India’ drugs supplied to the developed economies such as the US, EU, Japan and many other countries are known for their safety and quality, he noted.

The Government is promoting Bulk Drug Parks for financing Common Infrastructure facilities in 3 Bulk Drug Parks with financial implication of Rs.3,000 crore over next 5 years to boost domestic manufacturing of critical KSMs/Drug Intermediates and APIs.

Welcoming the Government decision, he assured wide support from FICCI and its pharma member companies. fiinews.com

Tags: FICCIPfizer
ShareTweetShare

Related Posts

Airbus
Manufacturing

Manufacture: PM to roll-out Vadodara’s aircraft

by Fiinews
February 6, 2026
0
11

Airbus growing strongly in India, say Van Wersch Prime Minister Narendra Modi is expected to officiate at the Tata-Airbus delivery...

VendeBharat logo
Manufacturing

Manufacture: 260 Vande Bharat Trainsets planned

by Fiinews
February 6, 2026
0
12

Minister aims to improve travel experience Minister for Railways Ashwini Vaishnaw has shared with parliament (Lok Sabha) plans to manufacture...

Trust fund

Manufacturing: BCIC to support MSMEs

February 6, 2026
15
Hirschvogel

Manufacturing: Hirschvogel commits Rs.750cr FDI in Davos

January 25, 2026
15
Kryon logo

Manufacturing: 5 selected under White Goods PLI

January 25, 2026
23
Chemvolt

Manufacturing: ChemVolt to set up BESS factory

January 21, 2026
14
SBI YONO

POPULAR NEWS

  • Cristina Dnv

    Projects: Indian yards set to build green ships, says DNV expert

    0 shares
    Share 0 Tweet 0
  • Market: Indian-origin UGF scales heritage consumer brands globally

    0 shares
    Share 0 Tweet 0
  • Technologies: Royal Diamond sponsors aerspace Industries’ drones in UAE

    0 shares
    Share 0 Tweet 0
  • Investments: Foreign investors see India as long-term destination for fund placings

    0 shares
    Share 0 Tweet 0
  • Markets: Blue Dart maintains positive outlook on India

    0 shares
    Share 0 Tweet 0

Fiinews.com features through news articles on business opportunities in the Indian market for the benefits of foreigners. It is also a platform for international businesses to showcase through elaborate articles on their products & services to the Indian consumers and corporations exploiting industrialisation of the country.

7Clicks Media is a Singapore based Media & PR company offering over 100,000
impressions via our targeted communication strategy.

It is led by editor-in-chief Gurdip Singh who has worked over 45 years reporting on
Asian businesses.

Recent News

  • Market: ST Engineering group seeks collaborations
  • Export: India-GCC ToRs signed for FTA talks
  • Tender: NTPC plans 30GW nuclear plant
  • Manufacture: PM to roll-out Vadodara’s aircraft
  • Tech: Experts see opportunities in space sector

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY

Subscribe to Newsletter

  • About
  • Advertise
  • Careers
  • Contact us

© 2024 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports

© 2024 FIINEWS - Design and developed by 7clicksmedia.